UK patients losing out in access to cancer drugs

Data shows ‘incomprehensible price rises’

Related items from OnMedica

75% of reappraised CDF drugs approved for NHS
Rising costs of generic medications
Pfizer fined a record £84.2m for overcharging
NHS cancer patients still denied treatments available in other countries
Study shows huge global variation in cancer drug costs

from OnMedica News http://ift.tt/2kFiAx8
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s